Ko­rea-based Bridge Bio­ther­a­peu­tics clos­es Boston of­fice

Bridge Bio­ther­a­peu­tics has closed its Boston-area dis­cov­ery wing, ac­cord­ing to sources fa­mil­iar with the de­ci­sion by the South Ko­re­an drug de­vel­op­er.

The clo­sure came in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.